Rock Springs Capital Management LP Aclaris Therapeutics, Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 6,204,309 shares of ACRS stock, worth $14.5 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
6,204,309
Previous 2,753,495
125.32%
Holding current value
$14.5 Million
Previous $3.11 Million
394.57%
% of portfolio
0.61%
Previous 0.11%
Shares
25 transactions
Others Institutions Holding ACRS
# of Institutions
107Shares Held
88.1MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$33.2 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$22.4 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$20.7 Million4.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$10.9 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$10.1 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $155M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...